It's well-known that previous doping paradigms affected the age distribution of the most successful riders.
Is there a link between the pharmaceutical causes of the rising peloton speed and stand-out performances on the one hand and just how well the very youngest pros perform on the other?
Evenepoel, Pogi, De Lie, Sheffield, Ayuso, Simmons, Poole, Martinez, Uijtdebroecks are all exceptional. But why are there so many exceptions now? I'm specifically talking about the performances of 18-year-olds, 19-year-olds and 20-years-olds.
When Sagan was exceptional at that age, he was indeed an exception. Mohorič turned pro when he was 19 in 2014, but he first made a major pro result in 2017.
Is there a link between the pharmaceutical causes of the rising peloton speed and stand-out performances on the one hand and just how well the very youngest pros perform on the other?
Evenepoel, Pogi, De Lie, Sheffield, Ayuso, Simmons, Poole, Martinez, Uijtdebroecks are all exceptional. But why are there so many exceptions now? I'm specifically talking about the performances of 18-year-olds, 19-year-olds and 20-years-olds.
When Sagan was exceptional at that age, he was indeed an exception. Mohorič turned pro when he was 19 in 2014, but he first made a major pro result in 2017.